Evidence map›Paper›PMID 28569174›Full record

ArticleParasites & vectors2017

Assessing the anthelmintic activity of pyrazole-5-carboxamide derivatives against Haemonchus contortus.

Yaqing Jiao, Sarah Preston, Hongjian Song, Abdul Jabbar, Yuxiu Liu, Jonathan Baell, Andreas Hofmann, Dana Hutchinson, Tao Wang, Anson V Koehler and 8 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Evaluation of Serum Supplementation on the Development ofInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Tetrahydroquinoxalines induce a lethal evisceration phenotype in Haemonchus contortus in vitro.International journal for parasitology. Drugs and drug resistance · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Yaqing JiaoFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
Sarah PrestonFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
Hongjian SongState Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Nankai University, Tianjin, 300071, China.
Abdul JabbarFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
Yuxiu LiuState Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Nankai University, Tianjin, 300071, China.
Jonathan BaellMedicinal Chemistry, Monash University Institute of Pharmaceutical Sciences (MIPS), Monash University, Parkville, VIC, 3052, Australia.
Andreas HofmannGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD, 4111, Australia.
Dana HutchinsonDrug Discovery Biology, Monash University Institute of Pharmaceutical Sciences (MIPS), Monash University, Parkville, VIC, 3052, Australia.
Tao WangFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
Anson V KoehlerFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
Gillian M FisherGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD, 4111, Australia.
Katherine T AndrewsGriffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, QLD, 4111, Australia.
Benoît LaleuMedicines for Malaria Venture (MMV), Route de Pré-Bois 20, CH-1215, Geneva, Switzerland.
Michael J PalmerMedicines for Malaria Venture (MMV), Route de Pré-Bois 20, CH-1215, Geneva, Switzerland.
Jeremy N BurrowsMedicines for Malaria Venture (MMV), Route de Pré-Bois 20, CH-1215, Geneva, Switzerland.
Timothy N C WellsMedicines for Malaria Venture (MMV), Route de Pré-Bois 20, CH-1215, Geneva, Switzerland.
Qingmin WangState Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Nankai University, Tianjin, 300071, China. wangqm@nankai.edu.cn.
Robin B GasserFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia. robinbg@unimelb.edu.au.
University of Melbourne · AUMedicines for Malaria Venture · CHGriffith University · AUNankai University · CNMonash University · AUHuazhong Agricultural University · CN

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundIn this study, we tested five series of pyrazole-5-carboxamide compounds (n = 55) for activity against parasitic stages of the nematode Haemonchus contortus (barber's pole worm), one of the most pathogenic parasites of ruminants.

methodsIn an optimised, whole-organism screening assay, using exsheathed third-stage (xL3) and fourth-stage (L4) larvae, we measured the inhibition of larval motility and development of H. contortus.

resultsAmongst the 55 compounds, we identified two compounds (designated a-15 and a-17) that reproducibly inhibit xL3 motility as well as L4 motility and development, with IC

conclusionsThe present findings provide a sound basis for future work, aimed at identifying the targets of compounds a-15 and a-17 and establishing the modes of action of these chemicals in H. contortus.

Indexed as

AnimalsAnthelminticsBiological AssayDrug Evaluation, PreclinicalHaemonchiasisHaemonchusLarvaMitochondriaMitochondrial DiseasesOxygen ConsumptionParasitic Sensitivity TestsPyrazolesQuaternary Ammonium CompoundsReproducibility of ResultsRuminantsToxicity TestsA 17Anthelminticspyrazole-5-carboxamidePyrazolesQuaternary Ammonium CompoundsHaemonchus contortusMitochondrial respiratory chainPhenotypic screeningSynthetic pyrazole-5-carboxamide derivativesTolfenpyrad

Identifiers

PMID28569174
PMCPMC5452367
OpenAlexW2616974170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.